Logo image of JXG

JX LUXVENTURE GROUP INC (JXG) Stock Fundamental Analysis

USA - NASDAQ:JXG - MHY460021535 - Common Stock

0.808 USD
+0.01 (+1.16%)
Last: 9/26/2025, 8:05:34 PM
0.7711 USD
-0.04 (-4.57%)
After Hours: 9/26/2025, 8:05:34 PM
Fundamental Rating

4

Taking everything into account, JXG scores 4 out of 10 in our fundamental rating. JXG was compared to 48 industry peers in the Textiles, Apparel & Luxury Goods industry. JXG has a medium profitability rating, but doesn't score so well on its financial health evaluation. JXG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year JXG was profitable.
In the past year JXG had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: JXG reported negative net income in multiple years.
JXG had negative operating cash flow in 4 of the past 5 years.
JXG Yearly Net Income VS EBIT VS OCF VS FCFJXG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

The Return On Assets of JXG (20.11%) is better than 95.83% of its industry peers.
Looking at the Return On Equity, with a value of 28.56%, JXG belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
With an excellent Return On Invested Capital value of 24.03%, JXG belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
Industry RankSector Rank
ROA 20.11%
ROE 28.56%
ROIC 24.03%
ROA(3y)-142.21%
ROA(5y)-106.68%
ROE(3y)-187.56%
ROE(5y)-138.71%
ROIC(3y)N/A
ROIC(5y)N/A
JXG Yearly ROA, ROE, ROICJXG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

Looking at the Profit Margin, with a value of 7.65%, JXG belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
JXG has a better Operating Margin (8.63%) than 70.83% of its industry peers.
In the last couple of years the Operating Margin of JXG has grown nicely.
Looking at the Gross Margin, with a value of 16.28%, JXG is doing worse than 89.58% of the companies in the same industry.
JXG's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.63%
PM (TTM) 7.65%
GM 16.28%
OM growth 3YN/A
OM growth 5Y25.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y120.04%
GM growth 5Y-13.65%
JXG Yearly Profit, Operating, Gross MarginsJXG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so JXG is creating value.
The number of shares outstanding for JXG has been increased compared to 1 year ago.
JXG has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, JXG has a worse debt to assets ratio.
JXG Yearly Shares OutstandingJXG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
JXG Yearly Total Debt VS Total AssetsJXG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

JXG has an Altman-Z score of 0.78. This is a bad value and indicates that JXG is not financially healthy and even has some risk of bankruptcy.
JXG has a Altman-Z score of 0.78. This is amonst the worse of the industry: JXG underperforms 85.42% of its industry peers.
JXG has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
JXG has a better Debt to Equity ratio (0.08) than 77.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 0.78
ROIC/WACC2.6
WACC9.24%
JXG Yearly LT Debt VS Equity VS FCFJXG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

JXG has a Current Ratio of 1.32. This is a normal value and indicates that JXG is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.32, JXG is not doing good in the industry: 79.17% of the companies in the same industry are doing better.
A Quick Ratio of 1.32 indicates that JXG should not have too much problems paying its short term obligations.
JXG has a better Quick ratio (1.32) than 70.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 1.32
JXG Yearly Current Assets VS Current LiabilitesJXG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.96% over the past year.
JXG shows a strong growth in Revenue. In the last year, the Revenue has grown by 46.19%.
Measured over the past years, JXG shows a very strong growth in Revenue. The Revenue has been growing by 24.79% on average per year.
EPS 1Y (TTM)16.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.96%
Revenue 1Y (TTM)46.19%
Revenue growth 3Y-2.66%
Revenue growth 5Y24.79%
Sales Q2Q%56.53%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JXG Yearly Revenue VS EstimatesJXG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.30 indicates a rather cheap valuation of JXG.
Compared to the rest of the industry, the Price/Earnings ratio of JXG indicates a rather cheap valuation: JXG is cheaper than 100.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of JXG to the average of the S&P500 Index (27.32), we can say JXG is valued rather cheaply.
Industry RankSector Rank
PE 0.3
Fwd PE N/A
JXG Price Earnings VS Forward Price EarningsJXG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than JXG, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.2
JXG Per share dataJXG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for JXG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JX LUXVENTURE GROUP INC

NASDAQ:JXG (9/26/2025, 8:05:34 PM)

After market: 0.7711 -0.04 (-4.57%)

0.808

+0.01 (+1.16%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.14%
Inst Owner ChangeN/A
Ins Owners14.64%
Ins Owner ChangeN/A
Market Cap9.69M
AnalystsN/A
Price TargetN/A
Short Float %1.5%
Short Ratio0.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.3
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF 1.26
P/B 0.46
P/tB 1.95
EV/EBITDA 1.2
EPS(TTM)2.68
EY331.68%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)0.64
OCFY79.57%
SpS6.51
BVpS1.74
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 20.11%
ROE 28.56%
ROCE 32.19%
ROIC 24.03%
ROICexc 25.36%
ROICexgc 99.73%
OM 8.63%
PM (TTM) 7.65%
GM 16.28%
FCFM N/A
ROA(3y)-142.21%
ROA(5y)-106.68%
ROE(3y)-187.56%
ROE(5y)-138.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y127.4%
ROICexc growth 3YN/A
ROICexc growth 5Y73.53%
OM growth 3YN/A
OM growth 5Y25.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y120.04%
GM growth 5Y-13.65%
F-Score4
Asset Turnover2.63
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA 0.23
Cap/Depr 4252.34%
Cap/Sales 15.7%
Interest Coverage 250
Cash Conversion 109.83%
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 1.32
Altman-Z 0.78
F-Score4
WACC9.24%
ROIC/WACC2.6
Cap/Depr(3y)1417.49%
Cap/Depr(5y)938.38%
Cap/Sales(3y)8.19%
Cap/Sales(5y)6.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)46.19%
Revenue growth 3Y-2.66%
Revenue growth 5Y24.79%
Sales Q2Q%56.53%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.75%
EBIT growth 3YN/A
EBIT growth 5Y57.22%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-0.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y270.58%
OCF growth 3YN/A
OCF growth 5YN/A